Last updated on: 08/11/2019
1. Contact details
Name of data sourceLa Paz University Hospital Electronic Prescriptions
Name under which the data source should be displayed in the inventory (e.g short name if one exists)LPUH-Drug Registry
Name of organisation
1) Department/research groupClinical Pharmacology Department
2) Organisation/affiliationHospital La Paz, School of Medicine, UAM
Administrative Contact
Title Dr
Last name Ramirez
First name Elena
Address line 1Servicio de Farmacología Clínica
Address line 2Hospital Universitario la Paz
Address line 3Paseo de la Castellana, 261
CityMADRID
Postcode28046
CountrySpain
Scientific Contact
Title Dr
Last name Ramirez
First name Elena
Address line 1Servicio de Farmacología Clínica
Address line 2Hospital Universitario la Paz
Address line 3Paseo de la Castellana 261
CityMADRID
Postcode28046
CountrySpain
Alternative Contact
Title Professor
Last name Frias
First name Jesus
Address line 1Servicio de Farmacología Clínica
Address line 2Hospital Universitario la Paz
Address line 3Paseo de la Castellana 261
CityMADRID
Postcode28046
CountrySpain
2. Description/category
Prescription event monitoring
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
Hospital data
3.2 ATC code (5th level)
Yes
3.3 Other product dictionaries
No
3.4 Recording of indication for use
No
4. Coverage of events
Event
Dictionary
Dictionary details
Specialist diagnosis
Yes
International Classification of Diseases, Ninth Revision, Clinical Modification codes
Discharge diagnosis
Yes
International Classification of Diseases, Ninth Revision, Clinical Modification codes
Laboratory values
Yes
International Classification of Diseases, Ninth Revision, Clinical Modification codes
5. Year of establishment
2008
6. Geographical origin of data
EEA/EFTA countries
Spain
7. Demographical extent of data collection
Regional sub-set :
Hospital La Paz
8. Age groups
18 to 45 years
46 to 64 years
65 years and over
65 to 75 years
76 years and over
9. Size of the source/catchment population
5,000,000
10 a. Total (cumulative) number of persons with actual data
100,000
10 b. Number of persons with active data collection in past calendar year
27,600
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
Yes
b) Questionnaire data from the patient?
Yes
c) Genetic information or samples?
Yes
12. Possibility of links to other sources of data
Yes :
record number
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
Yes
15. Charge/fee for data access
No
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
Ramirez E, Lei SH, Borobia AM, Piñana E, Fudio S, Muñoz R, Campos A, Carcas AJ, Frias J. Overuse of PPIs in patients at admission, during hospitalisation and at discharge in a tertiary Spanish hospital. Curr Clin Pharmacol 2010 Nov 1;5(4):288-97.
Ramírez E, García-Rodríguez J, Borobia AM, Ortega JM, Lei S, Barrios-Fernández A, Sánchez M, Carcas AJ, Herrero A, de la Ramírez E, Cabañas R, Laserna LS, Fiandor A, Tong H, Prior N, Calderón O, Medrano N, Bobolea I, Frías J, Quirce S. Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study. Clin Exp Allergy. 2013; 43(3):344-52.
Ramírez E, García-Rodríguez J, Borobia AM, Ortega JM, Lei S, Barrios-Fernández A, Sánchez M, Carcas AJ, Herrero A, de la Puente JM, Frías J. Use of antifungal agents in pediatric and adult high-risk areas. Eur J Clin Microbiol Infect Dis. 2012; 31(3):337-47
Ramírez E, Gómez-Gil R, Borobia AM, Moreno F, Zegarra C, Muñoz R, Reutero Z, de Montreuil C, González D, Hernández S, Herrero A, Gutiérrez A, Frías J.
Improving linezolid use decreases the incidence of resistance among Gram-positive microorganisms. Int J Antimicrob Agents. 2013; 41(2):174-8.
Ramírez E, Romero-Garrido JA, López-Granados E, Borobia AM, Pérez T, Medrano
N, Rueda C, Tong HY, Herrero A, Frías J. Symptomatic thromboembolic events in
patients treated with intravenous-immunoglobulins: Results from a retrospective
cohort study. Thromb Res. 2014 Jun;133(6):1045-51.
